NEUP
Neuphoria Therapeutics
NEUP
NEUP
8 hedge funds and large institutions have $273K invested in Neuphoria Therapeutics in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
75% less capital invested
Capital invested by funds: $1.1M → $273K (-$826K)
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$45.7K | |
| 2 | +$22.2K | |
| 3 | +$10.2K | |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$1.42K |
Top Sellers
| 1 | -$700K | |
| 2 | -$139K | |
| 3 | -$14.9K | |
| 4 |
Morgan Stanley
New York
|
-$233 |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$133 |